TickerFacts.

Medifast Inc (MED): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$110.60M
Year ended 2025-12-31
$97.48M
Trailing 12 months to 2026-06-30
-37.7%
3-year compound annual growth
-14.1%
5-year compound annual growth
+4.5%
10-year compound annual growth
$458.16M2009-12-31: $45.35M2010-12-31: $65.08M2011-12-31: $73.69M2012-12-31: $82.66M2013-12-31: $83.49M2014-12-31: $76.08M2015-12-31: $71.46M2016-12-31: $68.87M2017-12-31: $73.75M2018-12-31: $121.10M2019-12-31: $176.81M2020-12-31: $237.03M2021-12-31: $398.49M2022-12-31: $458.16M2023-12-31: $296.20M2024-12-31: $157.84M2025-12-31: $110.60M$110.60M
2009-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$110.60M-29.9%2026-02-17, From 2025-01-01
2024-12-31$157.84M-46.7%2026-02-17, From 2024-01-01
2023-12-31$296.20M-35.3%2026-02-17, From 2023-01-01
2022-12-31$458.16M+15.0%2025-02-18, From 2022-01-01
2021-12-31$398.49M+68.1%2024-02-20, From 2021-01-01
2020-12-31$237.03M+34.1%2023-02-21, From 2020-01-01
2019-12-31$176.81M+46.0%2022-02-23, From 2019-01-01
2018-12-31$121.10M+64.2%2021-02-26, From 2018-01-01
2017-12-31$73.75M+7.1%2020-03-02, From 2017-01-01
2016-12-31$68.87M-3.6%2019-03-01, From 2016-01-01
2015-12-31$71.46M-6.1%2018-03-16, From 2015-01-01
2014-12-31$76.08M-8.9%2017-03-16, From 2014-01-01
2013-12-31$83.49M+1.0%2016-03-15, From 2013-01-01
2012-12-31$82.66Mn/c2015-03-16, From 2012-01-01
2011-12-31$73.69M+13.2%2014-03-17, From 2011-01-01
2010-12-31$65.08M+43.5%2013-03-15, From 2010-01-01
2009-12-31$45.35Mn/a2012-03-15, From 2009-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Miscellaneous Food Preparations & Kindred Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Medifast Inc (MED)2025-12-31$110.60M-29.9%
Utz Brands, Inc. (UTZ)2025-12-28$1.08B+3.9%
Coffee Holding Co Inc (JVA)2025-10-31$80.87M+29.3%
McCormick & Co Inc (MKC)2025-11-30$4.25B+2.8%
Top Wealth Group Holding Ltd (TWG)2025-12-31$2.32M+3.5%

Compare MED, UTZ, JVA, MKC side by side · Screen every company in Miscellaneous Food Preparations & Kindred Products ↗